Daniel Krys Selected Research

Daniel Krys Research Topics

6	Breast Neoplasms (Breast Cancer) 09/2023 - 01/2018
5	Neoplasms (Cancer) 12/2020 - 01/2018
4	Hypoxia (Hypoxemia) 09/2023 - 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Triple Negative Breast Neoplasms 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2020

3	Estrogen ReceptorsIBA 09/2023 - 12/2019
2	Messenger RNA (mRNA)IBA 11/2020 - 01/2018
2	FructoseIBA 01/2018 - 01/2018
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018 - 01/2018
2	Glucose Transporter Type 5IBA 01/2018 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2018
1	azomycinIBA 09/2023
1	fluoroazomycin arabinosideIBA 09/2023
1	fluoromisonidazoleIBA 09/2023
1	4-(3-fluoropropyl)glutamic acidIBA 12/2020
1	Cystine (L-Cystine)IBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	AntiportersIBA 12/2020
1	Glutamic Acid (Glutamate)FDA Link 12/2020
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2020
1	Peptides (Polypeptides)IBA 11/2020
1	BombesinIBA 11/2020
1	Bombesin Receptors (Bombesin Receptor)IBA 11/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 11/2020
1	alovudineIBA 12/2019
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 12/2019
1	NucleosidesIBA 12/2019
1	Carrier Proteins (Binding Protein)IBA 12/2019
1	thymidine kinase 1IBA 12/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2018
1	Cytochalasin BIBA 01/2018
1	HexokinaseIBA 01/2018
1	HexosesIBA 01/2018

2	Therapeutics 09/2023 - 11/2020